» Articles » PMID: 36321189

Post-prostatic-massage Urine Exosomes of Men with Chronic Prostatitis/chronic Pelvic Pain Syndrome Carry Prostate-cancer-typical MicroRNAs and Activate Proto-oncogenes

Overview
Journal Mol Oncol
Date 2022 Nov 2
PMID 36321189
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has a high prevalence of up to 15% and accounts for 90-95% of prostatitis diagnoses, and yet its etiopathogenesis and link to prostate cancer (PCa) are still unclear. Here, we investigated microRNAs in exosomes isolated from blood and post-prostatic-massage urine of CP/CPPS type IIIb patients and healthy men. THP-1 monocytes (human leukemia monocytic cell line) were treated with exosomes and subjected to mRNA arrays "Cancer Inflammation and Immunity Crosstalk" and "Transcription Factors." Using The Cancer Genome Atlas, the expression of CP/CPPS-associated microRNAs was analyzed in PCa and normal prostate tissue. In silico functional studies were carried out to explore the disease ontology of CP/CPPS. In CP/CPPS, urine exosomes exhibited significant upregulation of eight PCa-specific microRNAs (e.g., hsa-miR-501, hsa-miR-20a, and hsa-miR-106), whose target genes were significantly enriched for GO terms, hallmark gene sets, and pathways specific for carcinogenesis. In THP-1 monocytes, CP/CPPS-derived urine exosomes induced upregulation of PCa-associated proinflammatory genes (e.g., CCR2 and TLR2) and proto-oncogene transcription factors (e.g., MYB and JUNB). In contrast, CP/CPPS-derived blood exosomes exhibited molecular properties similar to those of healthy men. Thus, CP/CPPS exhibits molecular changes that constitute a risk for PCa and should be considered in the development of PCa biomarkers and cancer screening programs.

Citing Articles

Research progress of extracellular vesicles in the pathogenesis of type IIIA chronic prostatitis.

Cheng L, Luo P, Li W, Chen Q, Gan L, Zhang F Front Immunol. 2025; 16:1496055.

PMID: 40034709 PMC: 11873842. DOI: 10.3389/fimmu.2025.1496055.


Comprehensive computational analysis of differentially expressed miRNAs and their influence on transcriptomic signatures in prostate cancer.

Aldakheel F, Alnajran H, Mateen A, Alduraywish S, AlQahtani M, Syed R Sci Rep. 2025; 15(1):3646.

PMID: 39881138 PMC: 11779938. DOI: 10.1038/s41598-025-85502-4.


The mendelian randomized study revealed the association of prostatitis with prostate cancer risk.

Chen J, Ye F, Shang K, Li N, Li C, He H Sci Rep. 2024; 14(1):24643.

PMID: 39428439 PMC: 11491451. DOI: 10.1038/s41598-024-76355-4.


Predicting surgical efficacy and diagnosing histological inflammation: the clinical significance of prostate exosome proteins in benign prostatic hyperplasia.

Teng Z, Jin C, Wang S, Han Z, Zhang Y, Wang Y Transl Androl Urol. 2024; 13(6):930-939.

PMID: 38983479 PMC: 11228684. DOI: 10.21037/tau-23-655.


Epithelial cells derived exosomal miR-203a-3p facilitates stromal inflammation of type IIIA chronic prostatitis/chronic pelvic pain syndrome by targeting DUSP5 and increasing MCP-1 generation.

Song G, Zhao F, Ni R, Deng B, Chen S, Hu R J Nanobiotechnology. 2024; 22(1):236.

PMID: 38724995 PMC: 11084011. DOI: 10.1186/s12951-024-02513-5.

References
1.
Tomaskovic I, Ruzic B, Trnski D, Kraus O . Chronic prostatitis/chronic pelvic pain syndrome in males may be an autoimmune disease, potentially responsive to corticosteroid therapy. Med Hypotheses. 2008; 72(3):261-2. DOI: 10.1016/j.mehy.2008.10.020. View

2.
Berg E, Houska P, Nesheim N, Schuppe H, Pilatz A, Fijak M . Chronic Prostatitis/Chronic Pelvic Pain Syndrome Leads to Impaired Semen Parameters, Increased Sperm DNA Fragmentation and Unfavorable Changes of Sperm Protamine mRNA Ratio. Int J Mol Sci. 2021; 22(15). PMC: 8346101. DOI: 10.3390/ijms22157854. View

3.
Magistro G, Wagenlehner F, Grabe M, Weidner W, Stief C, Nickel J . Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Eur Urol. 2015; 69(2):286-97. DOI: 10.1016/j.eururo.2015.08.061. View

4.
Li L, Chui R, Nakajima K, Oh B, Au H, Dahiya R . Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression. Cancer Res. 2000; 60(3):702-6. View

5.
Langston M, Horn M, Khan S, Pakpahan R, Doering M, Dennis L . A Systematic Review and Meta-analysis of Associations between Clinical Prostatitis and Prostate Cancer: New Estimates Accounting for Detection Bias. Cancer Epidemiol Biomarkers Prev. 2019; 28(10):1594-1603. PMC: 6774844. DOI: 10.1158/1055-9965.EPI-19-0387. View